Search

Search results

141 results found

Harvard Medical School Otolaryngology–Head and Neck Surgery Faculty Take the Podium at Annual ARO and TRIO Meetings

News: January 30, 2020

This week, Harvard Medical School's Department of Otolaryngology–Head and Neck Surgery (OHNS) had excellent representation at the 43rd annual Association for Research in Otolaryngology (ARO) MidWinter Meeting. Held in San Jose, California, our OHNS faculty contributed more than 138 posters, podium...

The Clinical Research Team

Page

Mechanisms of Post-Bariatric Hypoglycemia

Page

The purpose of this study is to learn more about the causes of hypoglycemia (low blood sugar) which develops in some individuals who have had bariatric surgery. This study involves the following: 4 visits to Joslin Diabetes Center over the course of 2 months. Medical history, physical exam, EKG...

Current Clinical Research Studies in the Patti Lab -

Page

For more information about current studies please email Hypoglycemiastudy@joslin.harvard.edu or call (617) 309-1940 Please let us know where you live, and if we may contact you regarding future in-person or potential remote studies. Studies of New Treatment Approaches for Hypoglycemia Lucidity Study...

Probe-Seq enables transcriptional profiling of specific cell types from heterogeneous tissue by RNA-based isolation

Publication: Journal Article

Amamoto, Ryoji, Mauricio Garcia, Emma West, Jiho Choi, Sylvain Lapan, Elizabeth Lane, Norbert Perrimon, and Constance Cepko. 2019. “Probe-Seq Enables Transcriptional Profiling of Specific Cell Types from Heterogeneous Tissue by RNA-Based Isolation”. Elife 8.

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Publication: Journal Article

Sun, Jennifer, Raj Maturi, David Boyer, John Wells, Victor Gonzalez, Robert Tansley, Helen Hernandez, Andreas Maetzel, Edward Feener, and Lloyd Paul Aiello. 2019. “One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients With Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study”. Ophthalmol Retina 3 (12): 1107-9.

Glassman, Adam, Wesley Beaulieu, Cynthia Stockdale, Roy Beck, Neil Bressler, Leanne Labriola, Michele Melia, Kristina Oliver, and Jennifer Sun. 2020. “Effect of Telephone Calls from a Centralized Coordinating Center on Participant Retention in a Randomized Clinical Trial”. Clin Trials, 1740774519894229.

Search

Search results

Harvard Medical School Otolaryngology–Head and Neck Surgery Faculty Take the Podium at Annual ARO and TRIO Meetings

The Clinical Research Team

Mechanisms of Post-Bariatric Hypoglycemia

Current Clinical Research Studies in the Patti Lab -

Probe-Seq enables transcriptional profiling of specific cell types from heterogeneous tissue by RNA-based isolation

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Neuro-Ophthalmology

Normal temporal discrimination in musician's dystonia is linked to aberrant sensorimotor processing

Site of Origin of the Ophthalmic Artery Influences the Risk for Retinal Versus Cerebral Embolic Events

Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial